One more push above 33... Kaboom! شراء

Exelixis, Inc.NASDAQ

الوصف

⋅ ٢٥ شباط فبراير ٢٠١٨ ٠٦:٢٣

Consistently performed in FDA approvals for last 2 years.
Last push above 33 sometime this year with accelerating revenues growth... TA roadmap is set.

Fibonacci

المزيد